anti-TNF Nanofitins (Affilogic)

N/A

Report date: 2025/06/11 10:40:54

Base Information

Drug Nameanti-TNF Nanofitins (Affilogic)
Drug Alias NameAFG-6AFG-5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffilogic Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAffilogic Laboratories
Inactive CompaniesFerring Pharmaceuticals Sa
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A